Article
Unveiling potential drug targets for hyperparathyroidism through genetic insights via Mendelian randomization and colocalization analyses
18 Mar 2024
Abstract excerpt
Hyperparathyroidism (HPT) manifests as a complex condition with a substantial disease burden. While advances have been made in surgical interventions and non-surgical pharmacotherapy for the management of hyperparathyroidism, radical options to halt underlying disease progression remain lacking. Identifying putative genetic drivers and exploring novel drug targets that can impede HPT progression remain critical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
